Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus | Zendy

D. Aguilar Marucco | Zendy; Lorenzo Veronese | Zendy; Daniel González de Requena | Zendy; Stefano Bonora | Zendy; Andrea Calcagno | Zendy; Ilaria Cavecchia | Zendy; Alessandro Sinicco | Zendy; Francesco Giuseppe De Rosa | Zendy; Giuseppe Cariti | Zendy; Giovanni Di Perri | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus

Author(s) -

D. Aguilar Marucco,

Lorenzo Veronese,

Daniel González de Requena,

Stefano Bonora,

Andrea Calcagno,

Ilaria Cavecchia,

Alessandro Sinicco,

Francesco Giuseppe De Rosa,

Giuseppe Cariti,

Giovanni Di Perri

Publication year - 2007

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkl497

Subject(s) - ribavirin , pegylated interferon , medicine , hepatitis c virus , hepatitis c , virology , viral load , interferon , lentivirus , immunology , human immunodeficiency virus (hiv) , virus , gastroenterology , viral disease

To evaluate the early anti-HIV activity of pegylated interferon (PEG-IFN) alfa-2a and ribavirin in HIV/hepatitis C virus (HCV) co-infected patients not receiving antiretroviral therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research